Addressing Barriers to Patient Care for People Living With Atopic Dermatitis


As the treatment landscape for AD continues to evolve and advance, it is essential that patients have access to effective treatments that can improve patient symptoms and reduce the impact of AD on a patient’s daily life.

- The characteristics of AD and the current treatment landscape
- The barriers patients, particularly those with moderate-to-severe AD, encounter when accessing care and approved treatments, including advanced systemic therapies
- The pathways, policies, and payer changes that could improve patient access to appropriate, timely care
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.